Role of glutathione in the regulation of epigenetic mechanisms in disease

Free Radical Biology and Medicine

Volumn 112, Issue , 2017, Pages 36-48

  García Giménez, José Luis ^a,b,c   Romá Mateo, Carlos ^a,b,c,d   Pérez Machado, Gisselle ^a,c   Peiró Chova, Lorena ^b   Pallardó, Federico V ^a,b,c  

^a CENTRO DE INVESTIGACIÓN BIOMÉDICA EN RED DE ENFERMEDADES RARAS CIBERER   (Spain)

^b Universitat de València ^*

^c UNIVERSITY OF VALENCIA   (Spain)

^d EUROPEAN UNIVERSITY OF VALENCIA   (Spain)

Author keywords

DNA methylation; Epigenetics; Glutathione; Histone; MicroRNAs; Rare diseases; S adenosylmethionine; S glutathionylation

Indexed keywords

CYSTATHIONINE BETA SYNTHASE; DNA; GLUTAREDOXIN; GLUTATHIONE; HISTONE; UNTRANSLATED RNA; MICRORNA; S ADENOSYLMETHIONINE;

ADAPTATION; DNA METHYLATION; DNA SEQUENCE; DOWN SYNDROME; EPIGENETICS; GENE CONTROL; GENE EXPRESSION; GLUTATHIONE METABOLISM; HISTONE CODE; HOMOCYSTINURIA; INHERITANCE; MALIGNANT NEOPLASM; METABOLIC DISORDER; NERVE DEGENERATION; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; RARE DISEASE; REVIEW; STRUCTURE ANALYSIS; ANIMAL; CHEMISTRY; DEGENERATIVE DISEASE; GENETIC EPIGENESIS; GENETICS; HUMAN; METABOLIC SYNDROME X; METABOLISM; NEOPLASM; NUCLEOSOME; PATHOLOGY; PROTEIN PROCESSING;

ANIMALS; DNA METHYLATION; EPIGENESIS, GENETIC; GLUTATHIONE; HISTONES; HUMANS; METABOLIC SYNDROME; MICRORNAS; NEOPLASMS; NEURODEGENERATIVE DISEASES; NUCLEOSOMES; PROTEIN PROCESSING, POST-TRANSLATIONAL; S-ADENOSYLMETHIONINE;

EID: 85024486710     PISSN: 08915849     EISSN: 18734596     Source Type: Journal    
DOI: 10.1016/j.freeradbiomed.2017.07.008     Document Type: Review

References (195)

1. Pallardo, F.V., Markovic, J., Garcia, J.L., Vina, J., Role of nuclear glutathione as a key regulator of cell proliferation. Mol. Asp. Med. 30:1–2 (2009), 77–85.
2. Diaz Vivancos, P., Wolff, T., Markovic, J., Pallardo, F.V., Foyer, C.H., A nuclear glutathione cycle within the cell cycle. Biochem. J. 431:2 (2010), 169–178.
3. Vivancos, P.D., Dong, Y., Ziegler, K., Markovic, J., Pallardo, F.V., Pellny, T.K., Verrier, P.J., Foyer, C.H., Recruitment of glutathione into the nucleus during cell proliferation adjusts whole-cell redox homeostasis in Arabidopsis thaliana and lowers the oxidative defence shield. Plant J. 64:5 (2010), 825–838.
4. Markovic, J., Borras, C., Ortega, A., Sastre, J., Vina, J., Pallardo, F.V., Glutathione is recruited into the nucleus in early phases of cell proliferation. J. Biol. Chem. 282:28 (2007), 20416–20424.
5. Markovic, J., Garcia-Gimenez, J.L., Gimeno, A., Vina, J., Pallardo, F.V., Role of glutathione in cell nucleus. Free Radic. Res. 44:7 (2010), 721–733.
6. Garcia-Gimenez, J.L., Markovic, J., Dasi, F., Queval, G., Schnaubelt, D., Foyer, C.H., Pallardo, F.V., Nuclear glutathione. Biochim. Biophys. Acta 1830:5 (2013), 3304–3316.
7. Cyr, A.R., Domann, F.E., The redox basis of epigenetic modifications: from mechanisms to functional consequences. Antioxid. Redox Signal. 15:2 (2011), 551–589.
8. de Luca, A., Moroni, N., Serafino, A., Primavera, A., Pastore, A., Pedersen, J.Z., Petruzzelli, R., Farrace, M.G., Pierimarchi, P., Moroni, G., Federici, G., Sinibaldi Vallebona, P., Lo Bello, M., Treatment of doxorubicin-resistant MCF7/Dx cells with nitric oxide causes histone glutathionylation and reversal of drug resistance. Biochem. J. 440:2 (2011), 175–183.
9. Garcia-Gimenez, J.L., Olaso, G., Hake, S., Bonisch, C., Wiedemann, S., Markovic, J., Dasi, F., Gimeno, A., Perez-Quilis, C., Capdevila, M., Palacios, O., Vina, J., Pallardo, F., Histone H3 glutathionylation in proliferating mammalian cells destabilizes nucleosomal structure. Antioxid. Redox Signal., 2013.
10. Garcia-Gimenez, J.L., Hernandez-Gil, J., Martinez-Ruiz, A., Castineiras, A., Liu-Gonzalez, M., Pallardo, F.V., Borras, J., Alzuet Pina, G., DNA binding, nuclease activity, DNA photocleavage and cytotoxic properties of Cu(II) complexes of N-substituted sulfonamides. J. Inorg. Biochem. 121 (2013), 167–178.
11. Dupont, C., Armant, D.R., Brenner, C.A., Epigenetics: definition, mechanisms and clinical perspective. Semin. Reprod. Med. 27:5 (2009), 351–357.
12. Campos, E.I., Stafford, J.M., Reinberg, D., Epigenetic inheritance: histone bookmarks across generations. Trends Cell Biol. 24 (2014), 664–674.
13. Heard, E., Martienssen, R.A., Transgenerational epigenetic inheritance: myths and mechanisms. Cell 157:1 (2014), 95–109.
14. Fullston, T., Ohlsson Teague, E.M., Palmer, N.O., DeBlasio, M.J., Mitchell, M., Corbett, M., Print, C.G., Owens, J.A., Lane, M., Paternal obesity initiates metabolic disturbances in two generations of mice with incomplete penetrance to the F2 generation and alters the transcriptional profile of testis and sperm microRNA content. FASEB J. 27:10 (2013), 4226–4243.
15. Marczylo, E.L., Amoako, A.A., Konje, J.C., Gant, T.W., Marczylo, T.H., Smoking induces differential miRNA expression in human spermatozoa: a potential transgenerational epigenetic concern?. Epigenetics 7:5 (2012), 432–439.
16. Bernstein, B.E., Stamatoyannopoulos, J.A., Costello, J.F., Ren, B., Milosavljevic, A., Meissner, A., Kellis, M., Marra, M.A., Beaudet, A.L., Ecker, J.R., Farnham, P.J., Hirst, M., Lander, E.S., Mikkelsen, T.S., Thomson, J.A., The NIH roadmap epigenomics mapping consortium. Nat. Biotechnol. 28:10 (2010), 1045–1048.
17. Sandoval, J., Esteller, M., Cancer epigenomics: beyond genomics. Curr. Opin. Genet. Dev. 22:1 (2012), 50–55.
18. Jones, P.A., Baylin, S.B., The epigenomics of cancer. Cell 128:4 (2007), 683–692.
19. Irizarry, R.A., Ladd-Acosta, C., Wen, B., Wu, Z., Montano, C., Onyango, P., Cui, H., Gabo, K., Rongione, M., Webster, M., Ji, H., Potash, J.B., Sabunciyan, S., Feinberg, A.P., The human colon cancer methylome shows similar hypo- and hypermethylation at conserved tissue-specific CpG island shores. Nat. Genet. 41:2 (2009), 178–186.
20. Tahiliani, M., Koh, K.P., Shen, Y., Pastor, W.A., Bandukwala, H., Brudno, Y., Agarwal, S., Iyer, L.M., Liu, D.R., Aravind, L., Rao, A., Conversion of 5-methylcytosine to 5-hydroxymethylcytosine in mammalian DNA by MLL partner TET1. Science 324:5929 (2009), 930–935.
21. Ito, S., Shen, L., Dai, Q., Wu, S.C., Collins, L.B., Swenberg, J.A., He, C., Zhang, Y., Tet proteins can convert 5-methylcytosine to 5-formylcytosine and 5-carboxylcytosine. Science 333:6047 (2011), 1300–1303.
22. He, Y.F., Li, B.Z., Li, Z., Liu, P., Wang, Y., Tang, Q., Ding, J., Jia, Y., Chen, Z., Li, L., Sun, Y., Li, X., Dai, Q., Song, C.X., Zhang, K., He, C., Xu, G.L., Tet-mediated formation of 5-carboxylcytosine and its excision by TDG in mammalian DNA. Science 333:6047 (2011), 1303–1307.
23. Cortellino, S., Xu, J., Sannai, M., Moore, R., Caretti, E., Cigliano, A., Le Coz, M., Devarajan, K., Wessels, A., Soprano, D., Abramowitz, L.K., Bartolomei, M.S., Rambow, F., Bassi, M.R., Bruno, T., Fanciulli, M., Renner, C., Klein-Szanto, A.J., Matsumoto, Y., Kobi, D., Davidson, I., Alberti, C., Larue, L., Bellacosa, A., Thymine DNA glycosylase is essential for active DNA demethylation by linked deamination-base excision repair. Cell 146:1 (2011), 67–79.
24. Spruijt, C.G., Gnerlich, F., Smits, A.H., Pfaffeneder, T., Jansen, P.W., Bauer, C., Munzel, M., Wagner, M., Muller, M., Khan, F., Eberl, H.C., Mensinga, A., Brinkman, A.B., Lephikov, K., Muller, U., Walter, J., Boelens, R., van Ingen, H., Leonhardt, H., Carell, T., Vermeulen, M., Dynamic readers for 5-(hydroxy)methylcytosine and its oxidized derivatives. Cell 152:5 (2013), 1146–1159.
25. Wu, H., D'Alessio, A.C., Ito, S., Wang, Z., Cui, K., Zhao, K., Sun, Y.E., Zhang, Y., Genome-wide analysis of 5-hydroxymethylcytosine distribution reveals its dual function in transcriptional regulation in mouse embryonic stem cells. Genes Dev. 25:7 (2011), 679–684.
26. Yamaguchi, S., Hong, K., Liu, R., Inoue, A., Shen, L., Zhang, K., Zhang, Y., Dynamics of 5-methylcytosine and 5-hydroxymethylcytosine during germ cell reprogramming. Cell Res. 23:3 (2013), 329–339.
27. Young, J.I., Züchner, S., Wang, G., Regulation of the epigenome by Vitamin C. Ann. Rev. Nutr. 35:1 (2015), 545–564.
28. Ma, Y., Fu, H., Zhang, C., Cheng, S., Gao, J., Wang, Z., Jin, W., Conde, J., Cui, D., Chiral antioxidant-based gold nanoclusters reprogram DNA epigenetic patterns. Sci. Rep., 6(1), 2016 33436-33436.
29. He, L., Hannon, G.J., MicroRNAs: small RNAs with a big role in gene regulation. Nat. Rev. Genet. 5:7 (2004), 522–531.
30. Ponting, C.P., Oliver, P.L., Reik, W., Evolution and functions of long noncoding RNAs. Cell 136:4 (2009), 629–641.
31. Hwang, H.W., Mendell, J.T., MicroRNAs in cell proliferation, cell death, and tumorigenesis. Br. J. Cancer 94:6 (2006), 776–780.
32. Garzon, R., Marcucci, G., Croce, C.M., Targeting microRNAs in cancer: rationale, strategies and challenges. Nat. Rev. Drug Discov. 9:10 (2010), 775–789.
33. Tay, Y., Zhang, J., Thomson, A.M., Lim, B., Rigoutsos, I., MicroRNAs to Nanog, Oct4 and Sox2 coding regions modulate embryonic stem cell differentiation. Nature 455:7216 (2008), 1124–1128.
34. Lytle, J.R., Yario, T.A., Steitz, J.A., Target mRNAs are repressed as efficiently by microRNA-binding sites in the 5′ UTR as in the 3′ UTR. Proc. Natl. Acad. Sci. USA 104:23 (2007), 9667–9672.
35. Vasudevan, S., Tong, Y., Steitz, J.A., Switching from repression to activation: microRNAs can up-regulate translation. Science 318:5858 (2007), 1931–1934.
36. Cheng, X., Ku, C.H., Siow, R.C., Regulation of the Nrf2 antioxidant pathway by microRNAs: new players in micromanaging redox homeostasis. Free Radic. Biol. Med. 64 (2013), 4–11.
37. Siow, R.C., H, J.F., Redox regulation of microRNAs in health and disease. Free Radic. Biol. Med. 64 (2013), 1–3.
38. Fierro-Fernández, M., Miguel, V., Lamas, S., Role of redoximiRs in fibrogenesis. Redox Biol. 7 (2016), 58–67.
39. Koziol, M.J., Rinn, J.L., RNA traffic control of chromatin complexes. Curr. Opin. Genet. Dev. 20:2 (2010), 142–148.
40. Pandey, R.R., Mondal, T., Mohammad, F., Enroth, S., Redrup, L., Komorowski, J., Nagano, T., Mancini-Dinardo, D., Kanduri, C., Kcnq1ot1 antisense noncoding RNA mediates lineage-specific transcriptional silencing through chromatin-level regulation. Mol. Cell 32:2 (2008), 232–246.
41. Wang, K.C., Chang, H.Y., Molecular mechanisms of long noncoding RNAs. Mol. Cell 43:6 (2011), 904–914.
42. Wang, K.C., Yang, Y.W., Liu, B., Sanyal, A., Corces-Zimmerman, R., Chen, Y., Lajoie, B.R., Protacio, A., Flynn, R.A., Gupta, R.A., Wysocka, J., Lei, M., Dekker, J., Helms, J.A., Chang, H.Y., A long noncoding RNA maintains active chromatin to coordinate homeotic gene expression. Nature 472:7341 (2011), 120–124.
43. Wu, H., Zhao, M., Yoshimura, A., Chang, C., Lu, Q., Critical link between epigenetics and transcription factors in the induction of autoimmunity: a comprehensive review. Clin. Rev. Allergy Immunol. 50:3 (2016), 333–344.
44. Downs, J.A., Nussenzweig, M.C., Nussenzweig, A., Chromatin dynamics and the preservation of genetic information. Nature 447:7147 (2007), 951–958.
45. Strahl, B.D., Allis, C.D., The language of covalent histone modifications. Nature 403:6765 (2000), 41–45.
46. Jenuwein, T., Allis, C.D., Translating the histone code. Science 293:5532 (2001), 1074–1080.
47. Sneppen, K., Dodd, I.B., A simple histone code opens many paths to epigenetics. PLoS Comput. Biol., 8(8), 2012, e1002643.
48. Önder, Ö., Sidoli, S., Carroll, M., Garcia, B.A., Progress in epigenetic histone modification analysis by mass spectrometry for clinical investigations. Expert Rev. Proteom. 12:5 (2015), 499–517.
49. Yen, C.-Y., Huang, H.-W., Shu, C.-W., Hou, M.-F., Yuan, S.-S.F., Wang, H.-R., Chang, Y.-T., Farooqi, A.A., Tang, J.-Y., Chang, H.-W., DNA methylation, histone acetylation and methylation of epigenetic modifications as a therapeutic approach for cancers. Cancer Lett. 373:2 (2016), 185–192.
50. Wang, H., Huang, Z.Q., Xia, L., Feng, Q., Erdjument-Bromage, H., Strahl, B.D., Briggs, S.D., Allis, C.D., Wong, J., Tempst, P., Zhang, Y., Methylation of histone H4 at arginine 3 facilitating transcriptional activation by nuclear hormone receptor. Science 293:5531 (2001), 853–857.
51. Wiedemann, S.M., Mildner, S.N., Bonisch, C., Israel, L., Maiser, A., Matheisl, S., Straub, T., Merkl, R., Leonhardt, H., Kremmer, E., Schermelleh, L., Hake, S.B., Identification and characterization of two novel primate-specific histone H3 variants, H3.X and H3.Y. J. Cell Biol. 190:5 (2010), 777–791.
52. Henikoff, S., McKittrick, E., Ahmad, K., Epigenetics, histone H3 variants, and the inheritance of chromatin states. Cold Spring Harb. Symp. Quant. Biol. 69 (2004), 235–243.
53. McKittrick, E., Gafken, P.R., Ahmad, K., Henikoff, S., Histone H3.3 is enriched in covalent modifications associated with active chromatin. Proc. Natl. Acad. Sci. USA 101:6 (2004), 1525–1530.
54. Hake, S.B., Allis, C.D., Histone H3 variants and their potential role in indexing mammalian genomes: the “H3 barcode hypothesis”. Proc. Natl. Acad. Sci. USA 103:17 (2006), 6428–6435.
55. Chow, J.C., Brown, C.J., Forming facultative heterochromatin: silencing of an X chromosome in mammalian females. Cell. Mol. Life Sci. 60:12 (2003), 2586–2603.
56. Hake, S.B., Garcia, B.A., Duncan, E.M., Kauer, M., Dellaire, G., Shabanowitz, J., Bazett-Jones, D.P., Allis, C.D., Hunt, D.F., Expression patterns and post-translational modifications associated with mammalian histone H3 variants. J. Biol. Chem. 281:1 (2006), 559–568.
57. Lachner, M., Jenuwein, T., The many faces of histone lysine methylation. Curr. Opin. Cell Biol. 14:3 (2002), 286–298.
58. Soldi, M., Bremang, M., Bonaldi, T., Biochemical systems approaches for the analysis of histone modification readout. Biochim. Biophys. Acta 1839:8 (2014), 657–668.
59. Xu, Y.M., Du, J.Y., Lau, A.T., Posttranslational modifications of human histone H3: an update. Proteomics 14:17–18 (2014), 2047–2060.
60. Valinluck, V., Tsai, H.H., Rogstad, D.K., Burdzy, A., Bird, A., Sowers, L.C., Oxidative damage to methyl-CpG sequences inhibits the binding of the methyl-CpG binding domain (MBD) of methyl-CpG binding protein 2 (MeCP2). Nucleic Acids Res. 32:14 (2004), 4100–4108.
61. Rahman, I., Marwick, J., Kirkham, P., Redox modulation of chromatin remodeling: impact on histone acetylation and deacetylation, NF-kappaB and pro-inflammatory gene expression. Biochem. Pharmacol. 68:6 (2004), 1255–1267.
62. Dwivedi, R.S., Herman, J.G., McCaffrey, T.A., Raj, D.S., Beyond genetics: epigenetic code in chronic kidney disease. Kidney Int. 79:1 (2011), 23–32.
63. Cencioni, C., Spallotta, F., Martelli, F., Valente, S., Mai, A., Zeiher, A.M., Gaetano, C., Oxidative stress and epigenetic regulation in ageing and age-related diseases. Int. J. Mol. Sci. 14:9 (2013), 17643–17663.
64. Kaelin, W.G. Jr., McKnight, S.L., Influence of metabolism on epigenetics and disease. Cell 153:1 (2013), 56–69.
65. Garcia-Gimenez, J.L., Pallardo, F.V., Maintenance of glutathione levels and its importance in epigenetic regulation. Front. Pharmacol., 5, 2014 88-88.
66. Kreuz, S., Fischle, W., Oxidative stress signaling to chromatin in health and disease. Epigenomics 8:6 (2016), 843–862.
67. Zhang, W., Moden, O., Mannervik, B., Differences among allelic variants of human glutathione transferase A2-2 in the activation of azathioprine. Chem. Biol. Interact. 186:2 (2010), 110–117.
68. Lu, H., Liu, X., Deng, Y., Qing, H., DNA methylation, a hand behind neurodegenerative diseases. Front. Aging Neurosci., 5, 2013, 85.
69. Theodossiou, T.A., Olsen, C.E., Jonsson, M., Kubin, A., Hothersall, J.S., Berg, K., The diverse roles of glutathione-associated cell resistance against hypericin photodynamic therapy. Redox Biol. 12 (2017), 191–197.
70. El Ali, Z., Deloménie, C., Botton, J., Pallardy, M., Kerdine-Römer, S., Dendritic cells' death induced by contact sensitizers is controlled by Nrf2 and depends on glutathione levels. Toxicol. Appl. Pharmacol., 2017.
71. Strojan, K., Lojk, J., Bregar, V.B., Veranič, P., Pavlin, M., Glutathione reduces cytotoxicity of polyethyleneimine coated magnetic nanoparticles in CHO cells. Toxicol. In Vitro Int. J. Publ. Assoc. BIBRA 41 (2017), 12–20.
72. Frau, M., Feo, F., Pascale, R.M., Pleiotropic effects of methionine adenosyltransferases deregulation as determinants of liver cancer progression and prognosis. J. Hepatol. 59:4 (2013), 830–841.
73. Niedzwiecki, M.M., Hall, M.N., Liu, X., Oka, J., Harper, K.N., Slavkovich, V., Ilievski, V., Levy, D., van Geen, A., Mey, J.L., Alam, S., Siddique, A.B., Parvez, F., Graziano, J.H., Gamble, M.V., Blood glutathione redox status and global methylation of peripheral blood mononuclear cell DNA in Bangladeshi adults. Epigenetics 8:7 (2013), 730–738.
74. Trivedi, M., Shah, J., Hodgson, N., Byun, H.M., Deth, R., Morphine induces redox-based changes in global dna methylation and retrotransposon transcription by inhibition of excitatory amino acid transporter type 3-mediated cysteine uptake. Mol. Pharmacol. 85:5 (2014), 747–757.
75. Yuan, C., Zhang, Y., Liu, Y., Zhang, T., Wang, Z., Enhanced GSH synthesis by Bisphenol A exposure promoted DNA methylation process in the testes of adult rare minnow Gobiocypris rarus. Aquat. Toxicol. 178 (2016), 99–105.
76. Trivedi, M.S., Hodgson, N.W., Walker, S.J., Trooskens, G., Nair, V., Deth, R.C., Epigenetic effects of casein-derived opioid peptides in SH-SY5Y human neuroblastoma cells. Nutr. Metab., 12, 2015, 54.
77. Finkelstein, J.D., Martin, J.J., Homocysteine. Int. J. Biochem. Cell. Biol. 32:4 (2000), 385–389.
78. Anderson, J.E., Restriction endonucleases and modification methylases. Curr. Opin. Struct. Biol. 3 (1993), 24–30.
79. Lu, S.C., Regulation of glutathione synthesis. Mol. Asp. Med. 30:1–2 (2009), 42–59.
80. Feng, Q., Wang, H., Ng, H.H., Erdjument-Bromage, H., Tempst, P., Struhl, K., Zhang, Y., Methylation of H3-lysine 79 is mediated by a new family of HMTases without a SET domain. Curr. Biol. 12:12 (2002), 1052–1058.
81. Trievel, R.C., Beach, B.M., Dirk, L.M., Houtz, R.L., Hurley, J.H., Structure and catalytic mechanism of a SET domain protein methyltransferase. Cell 111:1 (2002), 91–103.
82. Tibbetts, A.S., Appling, D.R., Compartmentalization of Mammalian folate-mediated one-carbon metabolism. Annu. Rev. Nutr. 30 (2010), 57–81.
83. Al-Gazali, L.I., Padmanabhan, R., Melnyk, S., Yi, P., Pogribny, I.P., Pogribna, M., Bakir, M., Hamid, Z.A., Abdulrazzaq, Y., Dawodu, A., James, S.J., Abnormal folate metabolism and genetic polymorphism of the folate pathway in a child with Down syndrome and neural tube defect. Am. J. Med. Genet. 103:2 (2001), 128–132.
84. Duncan, T.M., Reed, M.C., Nijhout, H.F., The relationship between intracellular and plasma levels of folate and metabolites in the methionine cycle: a model. Mol. Nutr. Food Res. 57:4 (2013), 628–636.
85. Pajares, M.A., Álvarez, L., Pérez-Sala, D., How are mammalian methionine adenosyltransferases regulated in the liver? A focus on redox stress. FEBS Lett. 587:12 (2013), 1711–1716.
86. Herrera, E.A., Cifuentes-Zuniga, F., Figueroa, E., Villanueva, C., Hernandez, C., Alegria, R., Arroyo-Jousse, V., Penaloza, E., Farias, M., Uauy, R., Casanello, P., Krause, B.J., N-Acetylcysteine, a glutathione precursor, reverts vascular dysfunction and endothelial epigenetic programming in intrauterine growth restricted guinea pigs. J. Physiol. 595:4 (2017), 1077–1092.
87. Campos, A.C., Molognoni, F., Melo, F.H., Galdieri, L.C., Carneiro, C.R., D'Almeida, V., Correa, M., Jasiulionis, M.G., Oxidative stress modulates DNA methylation during melanocyte anchorage blockade associated with malignant transformation. Neoplasia 9:12 (2007), 1111–1121.
88. Griffith, O.W., Depletion of glutathione by inhibition of biosynthesis. Methods Enzymol. 77 (1981), 59–63.
89. Boyland, E., Chasseaud, L.F., Enzyme-catalysed conjugations of glutathione with unsaturated compounds. Biochem. J. 104:1 (1967), 95–102.
90. Plummer, J.L., Smith, B.R., Sies, H., Bend, J.R., Chemical depletion of glutathione in vivo. Methods Enzymol. 77 (1981), 50–59.
91. Britten, R.A., Green, J.A., Broughton, C., Browning, P.G., White, R., Warenius, H.M., The relationship between nuclear glutathione levels and resistance to melphalan in human ovarian tumour cells. Biochem. Pharmacol. 41:4 (1991), 647–649.
92. Markovic, J., Mora, N.J., Broseta, A.M., Gimeno, A., de-la-Concepcion, N., Vina, J., Pallardo, F.V., The depletion of nuclear glutathione impairs cell proliferation in 3t3 fibroblasts. PLoS One, 4(7), 2009, e6413.
93. Sanchez-Gongora, E., Pastorino, J.G., Alvarez, L., Pajares, M.A., Garcia, C., Vina, J.R., Mato, J.M., Farber, J.L., Increased sensitivity to oxidative injury in chinese hamster ovary cells stably transfected with rat liver S-adenosylmethionine synthetase cDNA. Biochem. J. 319:Pt 3 (1996), 767–773.
94. Pajares, M.A., Duran, C., Corrales, F., Pliego, M.M., Mato, J.M., Modulation of rat liver S-adenosylmethionine synthetase activity by glutathione. J. Biol. Chem. 267:25 (1992), 17598–17605.
95. Martinez-Chantar, M.L., Pajares, M.A., Role of thioltransferases on the modulation of rat liver S-adenosylmethionine synthetase activity by glutathione. FEBS Lett. 397:2–3 (1996), 293–297.
96. Delgado, M., Perez-Miguelsanz, J., Garrido, F., Rodriguez-Tarduchy, G., Perez-Sala, D., Pajares, M.A., Early effects of copper accumulation on methionine metabolism. Cell. Mol. Life Sci. 65:13 (2008), 2080–2090.
97. Perez-Mato, I., Castro, C., Ruiz, F.A., Corrales, F.J., Mato, J.M., Methionine adenosyltransferase S-nitrosylation is regulated by the basic and acidic amino acids surrounding the target thiol. J. Biol. Chem. 274:24 (1999), 17075–17079.
98. Corrales, F.J., Ruiz, F., Mato, J.M., In vivo regulation by glutathione of methionine adenosyltransferase S-nitrosylation in rat liver. J. Hepatol. 31:5 (1999), 887–894.
99. Mato, J.M., Corrales, F.J., Lu, S.C., Avila, M.A., S-Adenosylmethionine: a control switch that regulates liver function. FASEB J. 16:1 (2002), 15–26.
100. Lindermayr, C., Saalbach, G., Bahnweg, G., Durner, J., Differential inhibition of Arabidopsis methionine adenosyltransferases by protein S-nitrosylation. J. Biol. Chem. 281:7 (2006), 4285–4291.
101. Abat, J.K., Saigal, P., Deswal, R., S-Nitrosylation – another biological switch like phosphorylation?. Physiol. Mol. Biol. Plants Physiol. Mol. Biol. Plants 14:2 (2008), 119–130.
102. Torres, L., Sandoval, J., Penella, E., Zaragoza, R., Garcia, C., Rodriguez, J.L., Vina, J.R., Garcia-Trevijano, E.R., In vivo GSH depletion induces c-myc expression by modulation of chromatin protein complexes. Free Radic. Biol. Med. 46:11 (2009), 1534–1542.
103. Kim, S.C., Sprung, R., Chen, Y., Xu, Y., Ball, H., Pei, J., Cheng, T., Kho, Y., Xiao, H., Xiao, L., Grishin, N.V., White, M., Yang, X.J., Zhao, Y., Substrate and functional diversity of lysine acetylation revealed by a proteomics survey. Mol. Cell 23:4 (2006), 607–618.
104. Choudhary, C., Kumar, C., Gnad, F., Nielsen, M.L., Rehman, M., Walther, T.C., Olsen, J.V., Mann, M., Lysine acetylation targets protein complexes and co-regulates major cellular functions. Science 325:5942 (2009), 834–840.
105. Teperino, R., Schoonjans, K., Auwerx, J., Histone methyl transferases and demethylases; can they link metabolism and transcription?. Cell Metab. 12:4 (2010), 321–327.
106. Lertratanangkoon, K., Scimeca, J.M., Prevention of bromobenzene toxicity by N-acetylmethionine: correlation between toxicity and the impairment in O- and S-methylation of bromothiocatechols. Toxicol. Appl. Pharmacol. 122:2 (1993), 191–199.
107. Lertratanangkoon, K., Orkiszewski, R.S., Scimeca, J.M., Methyl-donor deficiency due to chemically induced glutathione depletion. Cancer Res. 56:5 (1996), 995–1005.
108. Thomas, M., Nicklee, T., Hedley, D.W., Differential effects of depleting agents on cytoplasmic and nuclear non-protein sulphydryls: a fluorescence image cytometry study. Br. J. Cancer 72:1 (1995), 45–50.
109. Borroz, K.I., Buetler, T.M., Eaton, D.L., Modulation of gamma-glutamylcysteine synthetase large subunit mRNA expression by butylated hydroxyanisole. Toxicol. Appl. Pharmacol. 126:1 (1994), 150–155.
110. Deneke, S.M., Baxter, D.F., Phelps, D.T., Fanburg, B.L., Increase in endothelial cell glutathione and precursor amino acid uptake by diethyl maleate and hyperoxia. Am. J. Physiol. 257:4 Pt 1 (1989), L265–L271.
111. Phelps, D.T., Deneke, S.M., Baxter, D.F., Fanburg, B.L., Erythrocytes fail to induce glutathione in response to diethyl maleate or hyperoxia. Am. J. Physiol. 257:4 Pt 1 (1989), L272–L276.
112. Zee, R.S., Yoo, C.B., Pimentel, D.R., Perlman, D.H., Burgoyne, J.R., Hou, X., McComb, M.E., Costello, C.E., Cohen, R.A., Bachschmid, M.M., Redox regulation of sirtuin-1 by S-Glutathiolation. Antioxid. Redox Signal. 13:7 (2010), 1023–1032.
113. Kawai, K., Li, Y.S., Song, M.F., Kasai, H., DNA methylation by dimethyl sulfoxide and methionine sulfoxide triggered by hydroxyl radical and implications for epigenetic modifications. Bioorg. Med. Chem. Lett. 20:1 (2010), 260–265.
114. Lewandowska, J., Bartoszek, A., DNA methylation in cancer development, diagnosis and therapy – multiple opportunities for genotoxic agents to act as methylome disruptors or remediators. Mutagenesis 26:4 (2011), 475–487.
115. Goldberg, A.D., Banaszynski, L.A., Noh, K.M., Lewis, P.W., Elsaesser, S.J., Stadler, S., Dewell, S., Law, M., Guo, X., Li, X., Wen, D., Chapgier, A., DeKelver, R.C., Miller, J.C., Lee, Y.L., Boydston, E.A., Holmes, M.C., Gregory, P.D., Greally, J.M., Rafii, S., Yang, C., Scambler, P.J., Garrick, D., Gibbons, R.J., Higgs, D.R., Cristea, I.M., Urnov, F.D., Zheng, D., Allis, C.D., Distinct factors control histone variant H3.3 localization at specific genomic regions. Cell 140:5 (2010), 678–691.
116. Lewis, P.N., Chiu, S.S., Effect of histone H3 sulfhydryl modifications on histone-histone interactions and nucleosome formation and structure. Eur. J. Biochem. 109:2 (1980), 369–376.
117. Prior, C.P., Cantor, C.R., Johnson, E.M., Littau, V.C., Allfrey, V.G., Reversible changes in nucleosome structure and histone H3 accessibility in transcriptionally active and inactive states of rDNA chromatin. Cell 34:3 (1983), 1033–1042.
118. Zhou, M., Paša-Tolić, L., Stenoien, D.L., Profiling of histone post-translational modifications in mouse brain with high-resolution top-down mass spectrometry. J. Proteome Res. 16:2 (2017), 599–608.
119. Lee, C.F., Paull, T.T., Person, M.D., Proteome-wide detection and quantitative analysis of irreversible cysteine oxidation using long column UPLC-pSRM. J. Proteome Res. 12:10 (2013), 4302–4315.
120. Regland, B., Johansson, B.V., Gottfries, C.G., Homocysteinemia and schizophrenia as a case of methylation deficiency. J. Neural Transm. Gen. Sect. 98:2 (1994), 143–152.
121. Yao, J.K., Leonard, S., Reddy, R., Altered glutathione redox state in schizophrenia. Dis. Markers 22:1–2 (2006), 83–93.
122. Kuratomi, G., Iwamoto, K., Bundo, M., Kusumi, I., Kato, N., Iwata, N., Ozaki, N., Kato, T., Aberrant DNA methylation associated with bipolar disorder identified from discordant monozygotic twins. Mol. Psychiatry 13:4 (2008), 429–441.
123. Frey, B.N., Andreazza, A.C., Kunz, M., Gomes, F.A., Quevedo, J., Salvador, M., Goncalves, C.A., Kapczinski, F., Increased oxidative stress and DNA damage in bipolar disorder: a twin-case report. Prog. Neuropsychopharmacol. Biol. Psychiatry 31:1 (2007), 283–285.
124. James, S.J., Cutler, P., Melnyk, S., Jernigan, S., Janak, L., Gaylor, D.W., Neubrander, J.A., Metabolic biomarkers of increased oxidative stress and impaired methylation capacity in children with autism. Am. J. Clin. Nutr. 80:6 (2004), 1611–1617.
125. James, S.J., Melnyk, S., Jernigan, S., Cleves, M.A., Halsted, C.H., Wong, D.H., Cutler, P., Bock, K., Boris, M., Bradstreet, J.J., Baker, S.M., Gaylor, D.W., Metabolic endophenotype and related genotypes are associated with oxidative stress in children with autism. Am. J. Med. Genet. B Neuropsychiatr. Genet. 141B:8 (2006), 947–956.
126. Fuso, A., The 'golden age' of DNA methylation in neurodegenerative diseases. Clin. Chem. Lab. Med. 51:3 (2013), 523–534.
127. Richard, E., Desviat, L.R., Ugarte, M., Pérez, B., Oxidative stress and apoptosis in homocystinuria patients with genetic remethylation defects. J. Cell. Biochem. 114:1 (2013), 183–191.
128. Yi, P., Melnyk, S., Pogribna, M., Pogribny, I.P., Hine, R.J., James, S.J., Increase in plasma homocysteine associated with parallel increases in plasma S-adenosylhomocysteine and lymphocyte DNA hypomethylation. J. Biol. Chem. 275:38 (2000), 29318–29323.
129. Caudill, M.A., Wang, J.C., Melnyk, S., Pogribny, I.P., Jernigan, S., Collins, M.D., Santos-Guzman, J., Swendseid, M.E., Cogger, E.A., James, S.J., Intracellular S-adenosylhomocysteine concentrations predict global DNA hypomethylation in tissues of methyl-deficient cystathionine beta-synthase heterozygous mice. J. Nutr. 131:11 (2001), 2811–2818.
130. Thomas, P., Fenech, M., Methylenetetrahydrofolate reductase, common polymorphisms, and relation to disease. Vitam. Horm. 79 (2008), 375–392.
131. Tuck-Muller, C.M., Narayan, A., Tsien, F., Smeets, D.F., Sawyer, J., Fiala, E.S., Sohn, O.S., Ehrlich, M., DNA hypomethylation and unusual chromosome instability in cell lines from ICF syndrome patients. Cytogenet. Cell. Genet. 89:1–2 (2000), 121–128.
132. Richard, E., Desviat, L.R., Ugarte, M., Perez, B., Oxidative stress and apoptosis in homocystinuria patients with genetic remethylation defects. J. Cell. Biochem. 114:1 (2013), 183–191.
133. Hoffman, M., Hypothesis: hyperhomocysteinemia is an indicator of oxidant stress. Med. Hypotheses 77:6 (2011), 1088–1093.
134. Castro, R., Rivera, I., Ravasco, P., Camilo, M.E., Jakobs, C., Blom, H.J., de Almeida, I.T., 5,10-methylenetetrahydrofolate reductase (MTHFR) 677C->T and 1298A->C mutations are associated with DNA hypomethylation. J. Med. Genet. 41:6 (2004), 454–458.
135. Burda, P., Suormala, T., Heuberger, D., Schafer, A., Fowler, B., Froese, D.S., Baumgartner, M.R., Functional characterization of missense mutations in severe methylenetetrahydrofolate reductase deficiency using a human expression system. J. Inherit. Metab. Dis. 40:2 (2017), 297–306.
136. Mikael, L.G., Pancer, J., Jiang, X., Wu, Q., Caudill, M., Rozen, R., Low dietary folate and methylenetetrahydrofolate reductase deficiency may lead to pregnancy complications through modulation of ApoAI and IFN-gamma in spleen and placenta, and through reduction of methylation potential. Mol. Nutr. Food Res. 57:4 (2013), 661–670.
137. Choi, S.W., Friso, S., Epigenetics: a new bridge between nutrition and health. Adv. Nutr. 1:1 (2010), 8–16.
138. Niculescu, M.D., Zeisel, S.H., Diet, methyl donors and DNA methylation: interactions between dietary folate, methionine and choline. J. Nutr. 132:8 Suppl (2002), 2333S–2335S.
139. Taban-Shomal, O., Kilter, H., Wagner, A., Schorr, H., Umanskaya, N., Hubner, U., Bohm, M., Herrmann, W., Herrmann, M., The cardiac effects of prolonged vitamin B12 and folate deficiency in rats. Cardiovasc. Toxicol. 9:2 (2009), 95–102.
140. Niculescu, M.D., Craciunescu, C.N., Zeisel, S.H., Dietary choline deficiency alters global and gene-specific DNA methylation in the developing hippocampus of mouse fetal brains. FASEB J. 20:1 (2006), 43–49.
141. Majumdar, S., Mukherjee, S., Maiti, A., Karmakar, S., Das, A.S., Mukherjee, M., Nanda, A., Mitra, C., Folic acid or combination of folic acid and vitamin B(12) prevents short-term arsenic trioxide-induced systemic and mitochondrial dysfunction and DNA damage. Environ. Toxicol. 24:4 (2009), 377–387.
142. Ulrey, C.L., Liu, L., Andrews, L.G., Tollefsbol, T.O., The impact of metabolism on DNA methylation. Hum. Mol. Genet. 14:No 1 (2005), R139–R147.
143. Zhang, Y., Hodgson, N.W., Trivedi, M.S., Abdolmaleky, H.M., Fournier, M., Cuenod, M., Do, K.Q., Deth, R.C., Decreased brain levels of vitamin B12 in aging, autism and schizophrenia. PLoS One, 11(1), 2016, e0146797.
144. Elmore, C.L., Wu, X., Leclerc, D., Watson, E.D., Bottiglieri, T., Krupenko, N.I., Krupenko, S.A., Cross, J.C., Rozen, R., Gravel, R.A., Matthews, R.G., Metabolic derangement of methionine and folate metabolism in mice deficient in methionine synthase reductase. Mol. Genet. Metab. 91:1 (2007), 85–97.
145. Melnyk, S., Fuchs, G.J., Schulz, E., Lopez, M., Kahler, S.G., Fussell, J.J., Bellando, J., Pavliv, O., Rose, S., Seidel, L., Gaylor, D.W., James, S.J., Metabolic imbalance associated with methylation dysregulation and oxidative damage in children with autism. J. Autism Dev. Disord. 42:3 (2012), 367–377.
146. James, S.J., Melnyk, S., Jernigan, S., Hubanks, A., Rose, S., Gaylor, D.W., Abnormal transmethylation/transsulfuration metabolism and DNA hypomethylation among parents of children with autism. J. Autism Dev. Disord. 38:10 (2008), 1966–1975.
147. Wong, C.C., Meaburn, E.L., Ronald, A., Price, T.S., Jeffries, A.R., Schalkwyk, L.C., Plomin, R., Mill, J., Methylomic analysis of monozygotic twins discordant for autism spectrum disorder and related behavioural traits. Mol. Psychiatry 19:4 (2014), 495–503.
148. Siniscalco, D., Cirillo, A., Bradstreet, J.J., Antonucci, N., Epigenetic findings in autism: new perspectives for therapy. Int. J. Environ. Res. Publ. Health 10:9 (2013), 4261–4273.
149. Whiteley, P., Haracopos, D., Knivsberg, A.M., Reichelt, K.L., Parlar, S., Jacobsen, J., Seim, A., Pedersen, L., Schondel, M., Shattock, P., The ScanBrit randomised, controlled, single-blind study of a gluten- and casein-free dietary intervention for children with autism spectrum disorders. Nutr. Neurosci. 13:2 (2010), 87–100.
150. Bhargava, S., Tyagi, S.C., Nutriepigenetic regulation by folate-homocysteine-methionine axis: a review. Mol. Cell. Biochem. 387:1–2 (2014), 55–61.
151. Kennedy, G., Spence, V.A., McLaren, M., Hill, A., Underwood, C., Belch, J.J., Oxidative stress levels are raised in chronic fatigue syndrome and are associated with clinical symptoms. Free Radic. Biol. Med. 39:5 (2005), 584–589.
152. Fulle, S., Mecocci, P., Fano, G., Vecchiet, I., Vecchini, A., Racciotti, D., Cherubini, A., Pizzigallo, E., Vecchiet, L., Senin, U., Beal, M.F., Specific oxidative alterations in vastus lateralis muscle of patients with the diagnosis of chronic fatigue syndrome. Free Radic. Biol. Med. 29:12 (2000), 1252–1259.
153. Morris, G., Berk, M., Galecki, P., Maes, M., The emerging role of autoimmunity in myalgic encephalomyelitis/chronic fatigue syndrome (ME/cfs). Mol. Neurobiol. 49:2 (2014), 741–756.
154. de Vega, W.C., Vernon, S.D., McGowan, P.O., DNA methylation modifications associated with chronic fatigue syndrome. PLoS One, 9(8), 2014, e104757.
155. Yideng, J., Jianzhong, Z., Ying, H., Juan, S., Jinge, Z., Shenglan, W., Xiaoqun, H., Shuren, W., Homocysteine-mediated expression of SAHH, DNMTs, MBD2, and DNA hypomethylation potential pathogenic mechanism in VSMCs. DNA Cell Biol. 26:8 (2007), 603–611.
156. Castro, R., Rivera, I., Struys, E.A., Jansen, E.E., Ravasco, P., Camilo, M.E., Blom, H.J., Jakobs, C., Tavares de Almeida, I., Increased homocysteine and S-adenosylhomocysteine concentrations and DNA hypomethylation in vascular disease. Clin. Chem. 49:8 (2003), 1292–1296.
157. James, S.J., Melnyk, S., Pogribna, M., Pogribny, I.P., Caudill, M.A., Elevation in S-adenosylhomocysteine and DNA hypomethylation: potential epigenetic mechanism for homocysteine-related pathology. J. Nutr. 132:8 Suppl (2002), 2361S–2366S.
158. Summer, K.H., Eisenburg, J., Low content of hepatic reduced glutathione in patients with Wilson's disease. Biochem. Med. 34:1 (1985), 107–111.
159. Medici, V., Shibata, N.M., Kharbanda, K.K., LaSalle, J.M., Woods, R., Liu, S., Engelberg, J.A., Devaraj, S., Torok, N.J., Jiang, J.X., Havel, P.J., Lonnerdal, B., Kim, K., Halsted, C.H., Wilson's disease: changes in methionine metabolism and inflammation affect global DNA methylation in early liver disease. Hepatology 57:2 (2013), 555–565.
160. Perna, A.F., Ingrosso, D., Santo, N.G. De, Homocysteine and oxidative stress. Amino Acids 25:3-4 (2003), 409–417.
161. Vanzin, C.S., Biancini, G.B., Sitta, A., Wayhs, C.A., Pereira, I.N., Rockenbach, F., Garcia, S.C., Wyse, A.T., Schwartz, I.V., Wajner, M., Vargas, C.R., Experimental evidence of oxidative stress in plasma of homocystinuric patients: a possible role for homocysteine. Mol. Genet. Metab. 104:1–2 (2011), 112–117.
162. Robert, K., Nehme, J., Bourdon, E., Pivert, G., Friguet, B., Delcayre, C., Delabar, J.M., Janel, N., Cystathionine beta synthase deficiency promotes oxidative stress, fibrosis, and steatosis in mice liver. Gastroenterology 128:5 (2005), 1405–1415.
163. Heil, S.G., Riksen, N.P., Boers, G.H., Smulders, Y., Blom, H.J., DNA methylation status is not impaired in treated cystathionine beta-synthase (CBS) deficient patients. Mol. Genet. Metab. 91:1 (2007), 55–60.
164. Esse, R., Imbard, A., Florindo, C., Gupta, S., Quinlivan, E.P., Davids, M., Teerlink, T., Tavares de Almeida, I., Kruger, W.D., Blom, H.J., Castro, R., Protein arginine hypomethylation in a mouse model of cystathionine beta-synthase deficiency. FASEB J. 28:6 (2014), 2686–2695.
165. Pagano, G., Castello, G., Oxidative stress and mitochondrial dysfunction in Down syndrome. Adv. Exp. Med. Biol 724 (2012), 291–299.
166. Sulthana, S.M., Kumar, S.N., Sridhar, M.G., Bhat, B.V., Rao, K.R., Levels of non enzymatic antioxidants in Down syndrome. Indian J. Pediatr. 79:11 (2012), 1473–1476.
167. Brooksbank, B.W., Balazs, R., Superoxide dismutase, glutathione peroxidase and lipoperoxidation in Down's syndrome fetal brain. Brain Res. 318:1 (1984), 37–44.
168. Epstein, C.J., Avraham, K.B., Lovett, M., Smith, S., Elroy-Stein, O., Rotman, G., Bry, C., Groner, Y., Transgenic mice with increased Cu/Zn-superoxide dismutase activity: animal model of dosage effects in Down syndrome. Proc. Natl. Acad. Sci. USA 84:22 (1987), 8044–8048.
169. Kedziora, J., Bartosz, G., Down's syndrome: a pathology involving the lack of balance of reactive oxygen species. Free Radic. Biol. Med. 4:5 (1988), 317–330.
170. Muchova, J., Sustrova, M., Garaiova, I., Liptakova, A., Blazicek, P., Kvasnicka, P., Pueschel, S., Durackova, Z., Influence of age on activities of antioxidant enzymes and lipid peroxidation products in erythrocytes and neutrophils of Down syndrome patients. Free Radic. Biol. Med. 31:4 (2001), 499–508.
171. Zitnanova, I., Korytar, P., Aruoma, O.I., Sustrova, M., Garaiova, I., Muchova, J., Kalnovicova, T., Pueschel, S., Durackova, Z., Uric acid and allantoin levels in Down syndrome: antioxidant and oxidative stress mechanisms?. Clin. Chim. Acta 341:1–2 (2004), 139–146.
172. Pogribna, M., Melnyk, S., Pogribny, I., Chango, A., Yi, P., James, S.J., Homocysteine metabolism in children with Down syndrome: in vitro modulation. Am. J. Hum. Genet. 69:1 (2001), 88–95.
173. Jones, M.J., Farre, P., McEwen, L.M., Macisaac, J.L., Watt, K., Neumann, S.M., Emberly, E., Cynader, M.S., Virji-Babul, N., Kobor, M.S., Distinct DNA methylation patterns of cognitive impairment and trisomy 21 in Down syndrome. BMC Med. Genom., 6, 2013 58-58.
174. Kerkel, K., Schupf, N., Hatta, K., Pang, D., Salas, M., Kratz, A., Minden, M., Murty, V., Zigman, W.B., Mayeux, R.P., Jenkins, E.C., Torkamani, A., Schork, N.J., Silverman, W., Croy, B.A., Tycko, B., Altered DNA methylation in leukocytes with trisomy 21. PLoS Genet., 6(11), 2010 e1001212-e1001212.
175. Dahl, N., Pigg, M., Ristoff, E., Gali, R., Carlsson, B., Mannervik, B., Larsson, A., Board, P., Missense mutations in the human glutathione synthetase gene result in severe metabolic acidosis, 5-oxoprolinuria, hemolytic anemia and neurological dysfunction. Hum. Mol. Genet. 6:7 (1997), 1147–1152.
176. Tew, K.D., Townsend, D.M., Regulatory functions of glutathione S-transferase P1-1 unrelated to detoxification. Drug. Metab. Rev. 43:2 (2011), 179–193.
177. Ristoff, E., Larsson, A., Inborn errors in the metabolism of glutathione. Orphanet. J. Rare Dis., 2, 2007, 16.
178. DeAngelis, M., Pennington, K., Epigenetic mechanisms of the aging human retina. J. Exp. Neurosci., 9(Suppl 2), 2016 51–51.
179. O'Hagan, H.M., Wang, W., Sen, S., Destefano Shields, C., Lee, S.S., Zhang, Y.W., Clements, E.G., Cai, Y., Van Neste, L., Easwaran, H., Casero, R.A., Sears, C.L., Baylin, S.B., Oxidative damage targets complexes containing DNA methyltransferases, SIRT1, and polycomb members to promoter CpG Islands. Cancer Cell 20:5 (2011), 606–619.
180. Brautigam, L., Jensen, L.D., Poschmann, G., Nystrom, S., Bannenberg, S., Dreij, K., Lepka, K., Prozorovski, T., Montano, S.J., Aktas, O., Uhlen, P., Stuhler, K., Cao, Y., Holmgren, A., Berndt, C., Glutaredoxin regulates vascular development by reversible glutathionylation of sirtuin 1. Proc. Natl. Acad. Sci. USA 110:50 (2013), 20057–20062.
181. Savarino, A., Mai, A., Norelli, S., El Daker, S., Valente, S., Rotili, D., Altucci, L., Palamara, A.T., Garaci, E., “Shock and kill” effects of class I-selective histone deacetylase inhibitors in combination with the glutathione synthesis inhibitor buthionine sulfoximine in cell line models for HIV-1 quiescence. Retrovirology, 6, 2009, 52.
182. Chi, P., Allis, C.D., Wang, G.G., Covalent histone modifications – miswritten, misinterpreted and mis-erased in human cancers. Nat. Rev. Cancer 10:7 (2010), 457–469.
183. Manosalva, I., Gonzalez, A., Aging changes the chromatin configuration and histone methylation of mouse oocytes at germinal vesicle stage. Theriogenology 74:9 (2010), 1539–1547.
184. Salminen, A., Kauppinen, A., Hiltunen, M., Kaarniranta, K., Krebs cycle intermediates regulate DNA and histone methylation: epigenetic impact on the aging process. Ageing Res. Rev. 16 (2014), 45–65.
185. Shao, G.B., Wang, J., Zhang, L.P., Wu, C.Y., Jin, J., Sang, J.R., Lu, H.Y., Gong, A.H., Du, F.Y., Peng, W.X., Aging alters histone H3 lysine 4 methylation in mouse germinal vesicle stage oocytes. Reprod. Fertil. Dev., 2014.
186. Araki, Y., Mimura, T., The histone modification code in the pathogenesis of autoimmune diseases. Mediat. Inflamm., 2017, 2017 2608605-2608605.
187. Kim, H.Y., Glutaredoxin serves as a reductant for methionine sulfoxide reductases with or without resolving cysteine. Acta Biochim. Biophys. Sin. 44:7 (2012), 623–627.
188. Bowman, G.D., Poirier, M.G., Post-translational modifications of histones that influence nucleosome dynamics. Chem. Rev. 115:6 (2015), 2274–2295.
189. Druz, A., Betenbaugh, M., Shiloach, J., Glucose depletion activates mmu-miR-466h-5p expression through oxidative stress and inhibition of histone deacetylation. Nucleic Acids Res. 40:15 (2012), 7291–7302.
190. Yang, H., Wu, X.L., Wu, K.H., Zhang, R., Ju, L.L., Ji, Y., Zhang, Y.W., Xue, S.L., Zhang, Y.X., Yang, Y.F., Yu, M.M., MicroRNA-497 regulates cisplatin chemosensitivity of cervical cancer by targeting transketolase. Am. J. Cancer Res. 6:11 (2016), 2690–2699.
191. Berman, A.E., Chan, W.Y., Brennan, A.M., Reyes, R.C., Adler, B.L., Suh, S.W., Kauppinen, T.M., Edling, Y., Swanson, R.A., N-acetylcysteine prevents loss of dopaminergic neurons in the EAAC1-/- mouse. Ann. Neurol. 69:3 (2011), 509–520.
192. Kinoshita, C., Aoyama, K., Matsumura, N., Kikuchi-Utsumi, K., Watabe, M., Nakaki, T., Rhythmic oscillations of the microRNA miR-96-5p play a neuroprotective role by indirectly regulating glutathione levels. Nat. Commun., 5, 2014, 3823.
193. Kondratov, R.V., Vykhovanets, O., Kondratova, A.A., Antoch, M.P., Antioxidant N-acetyl-L-cysteine ameliorates symptoms of premature aging associated with the deficiency of the circadian protein BMAL1. Aging 1:12 (2009), 979–987.
194. Espinosa-Diez, C., Fierro-Fernandez, M., Sanchez-Gomez, F., Rodriguez-Pascual, F., Alique, M., Ruiz-Ortega, M., Beraza, N., Martinez-Chantar, M.L., Fernandez-Hernando, C., Lamas, S., Targeting of gamma-glutamyl-cysteine ligase by miR-433 reduces glutathione biosynthesis and promotes TGF-beta-dependent fibrogenesis. Antioxid. Redox Signal. 23:14 (2015), 1092–1105.
195. Fodinger, M., Horl, W.H., Sunder-Plassmann, G., Molecular biology of 5,10-methylenetetrahydrofolate reductase. J. Nephrol. 13 (2000), 20–33.